1 / 11

3΄,4΄- Dimethoxythioflavone induces endothelium-dependent vasorelaxation

Supplementary Figures. 3΄,4΄- Dimethoxythioflavone induces endothelium-dependent vasorelaxation through activation of EGF receptor Eun Jin Jang 1# , Young Mi Seok 2# , Jae In Lee 3 , Hyun Min Cho 1 , Uy Dong Sohn 4 and In Kyeom Kim 1,2,*

selah
Download Presentation

3΄,4΄- Dimethoxythioflavone induces endothelium-dependent vasorelaxation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figures 3΄,4΄-Dimethoxythioflavone induces endothelium-dependent vasorelaxation through activation of EGF receptor Eun Jin Jang1# , Young Mi Seok2#, Jae In Lee3, Hyun Min Cho1, Uy Dong Sohn4 and In Kyeom Kim1,2,* 1Department of Pharmacology, 2Cardiovascular Research Institute, Kyungpook National University School of Medicine, Daegu, 700-422, Republic of Korea; 3Department of Chemistry, Duksung Women’s University, Seoul 132-714, Korea: 4College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea. # These authors equally contributed to this paper. *Correspondence and Proofs In Kyeom Kim, M.D., Ph.D. Department of Pharmacology Kyungpook National University School of Medicine 101 Dongin-2-Ga Daegu, 700-422, Republic of Korea Tel: +82-53-420-4833 Fax: +82-53-426-7345 E-mail: inkim@knu.ac.kr

  2. Supplementary Fig. 1. O Supplement Fig. 1. Chemical structure of 3’,4’-dimethoxythioflavone.

  3. Supplementary Fig. 2. (b) (a) (d) (c)

  4. Supplement Fig. 2. Effect of ATP-sensitive K+ channels blocker glibenclamide (GB) and nonselective K+ channel blocker tetraethylammonium (TEA) on 3΄,4΄-dimethoxythioflavone-induced vasorelaxation. 3΄,4΄-Dimethoxythioflavone was added cumulatively to elicit relaxation when vascular contractions induced by KCl (50 mmol/L; a, c) or U46619 (100 nmol/L; b, d) reached plateaus in endothelium-intact rat aortic rings. Rings were pretreated with GB (1.0 or 10 μmol/L; a, b), TEA (10 or 100 μmol/L; c, d), or vehicle (0.1% DMSO) for 30 min. Relaxation is expressed as a percentage of the maximal contraction. Data are the mean ± SEM of n=4 experiments.

  5. Supplementary Fig. 3. (a) (b)

  6. Supplement Fig. 3. Effect of cyclooxygenase blockers indomethacin on 3΄,4΄-dimethoxythioflavone-induced vasorelaxation. 3΄,4΄-Dimethoxythioflavone was added cumulatively to elicit relaxation when vascular contraction induced by KCl (50 mmol/L; a), U46619 (100 nmol/L; b) (b) reached plateaus in endothelium-intact rat aortic rings pretreated with indomethacin (1.0 or 10 μmol/L) or vehicle (0.1% DMSO) for 30 min. Relaxation is expressed as a percentage of the maximal contraction. Data are the mean ± SEM of n=4 experiments.

  7. Supplementary Fig. 4. (a) (b)

  8. Supplement Fig. 4. Effect of muscarinic receptor antagonist atropine on 3΄,4΄-dimethoxythioflavone-induced vasorelaxation. 3΄,4΄-Dimethoxythioflavone was added cumulatively to elicit relaxation when vascular contractions induced by KCl (50 mmol/L; a) or U46619 (100 nmol/L; b) reached plateaus in endothelium-intact rat aortic rings pretreated with atropine (1.0 or 10 μmol/L) or vehicle (0.1% DMSO) for 30 min. Relaxation is expressed as a percentage of the maximal contraction. Data are the mean ± SEM of n=4 experiments.

  9. Supplementary Fig. 5. (b) (a) ET (-) ET (-) ET (-) (d) (c) ET (-) ET (-)

  10. Supplement Fig. 5. Effect of a Src inhibitor PPT and an ERK inhibitor U0126 on 3΄,4΄-dimethoxythioflavone-induced vasorelaxation. 3΄,4΄-Dimethoxythioflavone was added cumulatively to elicit relaxation when vascular contractions induced by KCl (50 mmol/L; a, c) or U46619 (100 nmol/L; b, d) reached plateaus in endothelium-denuded rat aortic rings pretreated with PPT (0.1, 1.0 or 10 μmol/L), U0126 (0.1, 1.0 or 10 μmol/L), or vehicle (0.1% DMSO) for 30 min. Relaxation is expressed as a percentage of the maximal contraction. Data are the mean ± SEM of n=4 experiments.

  11. Table. 1. The maximum tension (mN) produced by KCl, U46619 or phenylephrine in rat aortic rings with intact or denuded-endothelium Data are expressed as means ± SEM of four experiments.

More Related